Christopher P. Cannon

Statistics

Publications

Citations

178

H-Index

Active since

1993

Affiliations

Brigham and Women's Hospital(Current)

The University of Texas Southwestern Medical Center

Thrombolysis in Myocardial Infarction Study Group

Harvard University

Christopher P. Cannon is an author at Brigham and Women's Hospital specializing in cardiovascular pharmacotherapy, medicine, and clinical pharmacology.

Publications per year

1993–2020

Publications

Anticoagulant effects of hirulog, ∗∗Hirulog™ brand direct thrombin inhibitor. a novel thrombin inhibitor, in patients with coronary artery disease

Christopher P. Cannon, John M. Maraganore, Joseph Loscalzo et al. · The American Journal of Cardiology · 1993 · 82 citations

Medicine, Cardiology, Pharmacology +17

NSAID Use and Association with Cardiovascular Outcomes in Outpatients with Stable Atherothrombotic Disease

Payal Kohli, Philippe Gabríel Steg, Christopher P. Cannon et al. · The American Journal of Medicine · 2013 · 61 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Learning from the Recently Completed Oral Glycoprotein IIb/IIIa Receptor Antagonist Trials

Christopher P. Cannon · Clinical Cardiology · 2000 · 19 citations · Full text

Medicine, Cardiology, Pharmacology +16

Association of Baseline Low-Density Lipoprotein Cholesterol and Percentage Low-Density Lipoprotein Cholesterol Reduction With Statins, Ezetimibe, and PCSK9 Inhibition

Daniel P. Marcusa, Robert P. Giugliano, Jeong‐Gun Park et al. · JAMA Cardiology · 2020 · 16 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

1–4 of 4